Brain risk insights - BrainScan by Neurocode —now in Australia
Find out how insights of p-tau217, GFAP and NfL can support your patients.
What Is BrainScan?
The BrainScan by Neurocode blood test panel measures three key blood markers.
1
High-sensitivity p-tau 217
p-tau217
Closely aligned with amyloid pathology. Highly predictive of Alzheimer's risk — one of the most significant advances in early brain risk assessment.
2
Glial Fibrillary Acidic Protein
GFAP
Provides insights into levels of brain inflammation and injury — an early signal of neurological stress before symptoms appear.
3
Neurofilament Light Chain
NfL
Provides insights into nerve cell damage and neurodegeneration — a marker of the health and integrity of neural networks.
Practitioner Education
Cognevity is an education partner of OptiLabs for BrainScan in Australia.
Practitioner education covers the science behind each biomarker, when testing is appropriate, how to order the test, and how to interpret results — including what they can and cannot tell you.
Available via video call or in-person for Sydney-based groups.
Get in touch
Like to know more or have questions — send a message.